Vincristine-induced Polyneuropathy at FDG PET/CT

Radiology. 2019 Oct;293(1):36. doi: 10.1148/radiol.2019190861. Epub 2019 Aug 13.

Authors

Kwok Sing Ng¹, Joyce May Sum Leung¹

Affiliation

¹ From the Nuclear Medicine Unit and Clinical PET Centre, Department of Radiology and Imaging, Queen Elizabeth Hospital, Hong Kong (K.S.N.); and Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong (J.M.S.L.).

PMID: 31407973
DOI: 10.1148/radiol.2019190861

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents, Phytogenic / adverse effects
Fatal Outcome
Female
Fluorodeoxyglucose F18*
Humans
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Middle Aged
Polyneuropathies / chemically induced*
Polyneuropathies / diagnostic imaging*
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals
Vincristine / adverse effects*
Whole Body Imaging

Substances

Antineoplastic Agents, Phytogenic
Radiopharmaceuticals
Fluorodeoxyglucose F18
Vincristine